Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | AMGN | VRTX | BMY | GILD |
| Company | Rayzebio Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 62.49 | 291.50 | 478.56 | 58.16 | 91.71 |
| High | 62.50 | 291.50 | 479.94 | 58.36 | 91.99 |
| Low | 62.48 | 282.16 | 467.76 | 56.92 | 90.19 |
| Last | 62.49 | 284.67 | 464.77 | 56.92 | 89.98 |
| Change | +0.01 | -11.26 | -19.19 | -1.58 | -2.13 |
| % Change | +0.02% | -3.80% | -3.97% | -2.70% | -2.31% |
| Volume | 282,700 | 837,995 | 241,065 | 3,179,393 | 1,392,086 |
| 20-Day Average Volume | 318,060 | 2,272,995 | 1,075,777 | 10,586,927 | 6,808,807 |
| Previous Close | 62.48 | 295.93 | 483.96 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 313.99 | 483.34 | 54.96 | 90.80 |
| 20-Day Raw Stochastic | 95.83% | 4.97% | 11.11% | 58.79% | 38.27% |
| 20-Day Relative Strength | 86.10% | 28.87% | 45.86% | 59.85% | 55.93% |
| Weighted Alpha | N/A | -0.68 | +26.06 | +21.55 | +28.25 |
| Today's Opinion | N/A | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Previous Opinion | N/A | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | N/A | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -12.51% since 11/08/24 | -9.15% since 11/08/24 | +5.76% since 11/08/24 | -6.08% since 11/08/24 |
| Low | 62.42 on 02/16/24 | 282.30 on 11/15/24 | 468.15 on 11/15/24 | 57.04 on 11/15/24 | 90.24 on 11/15/24 |
| High | 62.51 on 02/22/24 | 327.58 on 11/11/24 | 518.35 on 11/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -12.46% since 10/15/24 | -3.07% since 10/15/24 | +8.53% since 10/15/24 | +5.67% since 10/15/24 |
| Low | 61.86 on 01/24/24 | 282.30 on 11/15/24 | 463.14 on 11/01/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 62.51 on 02/22/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | -12.54% since 08/15/24 | -0.54% since 08/15/24 | +16.60% since 08/15/24 | +21.99% since 08/15/24 |
| Low | 22.14 on 11/27/23 | 282.30 on 11/15/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 62.51 on 02/22/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | -10.80% since 05/15/24 | +7.31% since 05/15/24 | +28.53% since 05/15/24 | +35.34% since 05/15/24 |
| Low | 17.95 on 09/26/23 | 282.30 on 11/15/24 | 432.22 on 05/16/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 62.51 on 02/22/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 59,920 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -68,600,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -18,190,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 03/04/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |